Tag Archives: Says

GlaxoSmithKline's investors have come around on Tesaro deal, executive says

GlaxoSmithKline investors cheered when the company said it would finally spin off its consumer unit after swallowing Pfizer’s. But the company’s other December deal, for Tesaro, didn’t sit quite so well at first. When GSK first unveiled the $ 5.1 billion pact—which closed Tuesday—investors weren’t surprised that the company had made a move in pharma,… Read More »

Happiness exercises boost moods of those recovering from addiction says MGH study

Short writing exercises reliving happy moments boosted the moods of adults recovering from addiction in a study conducted by researchers at Massachusetts General Hospital’s (MGH) Recovery Research Institute. “Recovery is hard,” said lead author Bettina B. Hoeppner, senior research scientist at the institute and an associate professor of psychology at Harvard Medical School. “For the… Read More »

JPM: Years into troubled launch, vaccine head says Sanofi's learned some Dengvaxia lessons

SAN FRANCISCO—To make sense of Sanofi’s Dengvaxia experiences, look no further than the old adage: Learn from your mistakes. It’s no secret that Sanofi has had a rough time marketing its world-first dengue vaccine, and at the J.P. Morgan Healthcare Conference, vaccine head David Loew told FiercePharma the company gleaned some lessons from the troubled… Read More »